Home/Vor Biopharma/Jeremy Sokolove, MD
JS

Jeremy Sokolove, MD

Chief Medical Officer

Vor Biopharma

Vor Biopharma Pipeline

DrugIndicationPhase
TelitaciceptMyasthenia Gravis (MG)Phase 3